1-7 of 7
H. Grant Prentice
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

Clinical Trials & Observations
Jacob M. Rowe, Georgina Buck, Alan K. Burnett, Raj Chopra, Peter H. Wiernik, Susan M. Richards, Hillard M. Lazarus, Ian M. Franklin, Mark R. Litzow, Niculae Ciobanu, H. Grant Prentice, Jill Durrant, Martin S. Tallman, Anthony H. Goldstone, for ECOG and the MRC/NCRI Adult Leukemia Working Party
Journal: Blood
Blood (2005) 106 (12): 3760–3767.
https://doi.org/10.1182/blood-2005-04-1623
Published: 2005
Journal Articles

Identical-Twin Transplants for B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Steven Pavletic, MD, Guimei Zhou, MD, Kathleen Sobocinski, MS, Kristine Doney, MD, John DiPersio, MD, Walter Feremans, MD, Letizia Foroni, MD, H. Grant Prentice, MBBS, Charles LeMaistre, MD, Giuseppe Bandini, MD, Augustin Ferrant, MD, Niels Jacobsen, MD, Issa Khouri, MD, Robert Peter Gale, MD, Sergio Giralt, MD, Emilio Montserrat, MD, John Chan, MD, Christopher Bredeson, MD
Journal: Blood
Blood (2004) 104 (11): 3330.
https://doi.org/10.1182/blood.V104.11.3330.3330
Published: 2004
Journal Articles

Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis

Dylan T. Jones, Kanagasabai Ganeshaguru, Robert J. Anderson, Trevor R. Jackson, K. Richard Bruckdorfer, Sylvia Y. Low, Lars Palmqvist, H. Grant Prentice, A. Victor Hoffbrand, Atul B. Mehta, R. Gitendra Wickremasinghe
Journal: Blood
Blood (2003) 101 (8): 3174–3180.
https://doi.org/10.1182/blood-2002-07-2143
Published: 2003
Journal Articles

Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or γ radiation

Dylan T. Jones, Kanagasabai Ganeshaguru, Andres E. Virchis, Najeem I. Folarin, Mark W. Lowdell, Atul B. Mehta, H. Grant Prentice, A. Victor Hoffbrand, R. Gitendra Wickremasinghe
Journal: Blood
Blood (2001) 98 (9): 2800–2807.
https://doi.org/10.1182/blood.V98.9.2800
Published: 2001
Journal Articles

Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis

Clinical Trials & Observations
Cesare Guglielmi, William Arcese, Jo Hermans, Andrea Bacigalupo, Giuseppe Bandini, Donald Bunjes, Enric Carreras, Agnès Devergie, Francesco Frassoni, John Goldman, Alois Gratwohl, Hans-Jochem Kolb, Anna P. Iori, Dietger Niederwieser, H. Grant Prentice, Theo de Witte, Jane Apperley
Journal: Blood
Blood (2000) 95 (11): 3328–3334.
https://doi.org/10.1182/blood.V95.11.3328
Published: 2000
Journal Articles

Improving the Outcome of Bone Marrow Transplantation by Using CD52 Monoclonal Antibodies to Prevent Graft-Versus-Host Disease and Graft Rejection

Geoff Hale, Mei-Jie Zhang, Donald Bunjes, H. Grant Prentice, David Spence, Mary M. Horowitz, A. John Barrett, Herman Waldmann
Journal: Blood
Blood (1998) 92 (12): 4581–4590.
https://doi.org/10.1182/blood.V92.12.4581
Published: 1998
Journal Articles

Molecular Typing Shows a High Level of HLA Class I Incompatibility in Serologically Well Matched Donor/Patient Pairs: Implications for Unrelated Bone Marrow Donor Selection

Iain Scott, John O’Shea, Mike Bunce, Jean-Marie Tiercy, J. Rafael Argüello, Helen Firman, John Goldman, H. Grant Prentice, Ann-Margaret Little, J. Alejandro Madrigal
Journal: Blood
Blood (1998) 92 (12): 4864–4871.
https://doi.org/10.1182/blood.V92.12.4864
Published: 1998